Robert Puopolo > Goodwin > Boston, United States > Lawyer Profile

Goodwin
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
Robert Puopolo photo

Position

Partner

Career

Rob Puopolo, a partner in Goodwin’s Life Sciences group, focuses his practice on representing public and privately held life sciences companies, as well as the venture capital firms, investment banks and hedge funds that focus on these companies.

Rob also serves on many committees within Goodwin’s Life Sciences business unit, including: the European Committee, the Capital Markets Committee, and the Diversity, Equity + Inclusion committee, through which he serves as a mentor to associates and junior partners and is an active advocate of the firm’s broader diversity and inclusion efforts.

Education

J.D., 1998 Suffolk University School of Law (cum laude) / B.A., 1993 Northeastern University

Lawyer Rankings

United States > Healthcare > Life sciences

(Next Generation Partners)

Robert PuopoloGoodwin

Goodwin’s global practice advises biotech, pharma, and healthcare companies, along with life science venture capital and investment firms. The growing practice supports clients in matters as wide-ranging as regulatory compliance, IP and M&A. The team’s representation of Prime Medicine in its $3.5bn deal with Bristol Myers Squibb evidences its excellence in research collaboration and license agreement matters. The practice is headed by Kingsley Taft, vastly experienced in commercial, financing and capital market transactions, and Mitchell Bloom, who specializes in emerging companies and life sciences investors. Both in Boston, transactional lawyer Robert Puopolo and Marishka DeToy, who focuses on capital markets and corporate matters, are key figures in the practice. In DC, Steven Tjoe focuses on product development strategies and FDA regulatory counseling. Arriving on the Boston-based team from Cooley LLP are Joshua Rottner, venture capital and growth equity funds specialist, and Michael McGrail, focused on medical devices and life sciences. Other key hires include litigation expert Michael Siekman, arriving in Boston from McDermott Will & Emery LLP, M&A specialist Amanda Gill, from Paul, Weiss, Rifkind, Wharton & Garrison LLP, and IP lawyer Carl Morales, from Fenwick & West LLP; the latter two are based in New York.

United States > Finance > Capital markets: equity offerings

Overseeing high-profile public offerings for an underwriting syndicate and advising issuers on both debt and equity follow-on offerings, Goodwin draws upon strong multi-jurisdictional capabilities and substantial bench-strength. The practice mainly represents private companies in complex financings and IPOs, alongside supporting public corporations in their SEC reporting and corporate governance proceedings. Edwin O’Connor heads the New York offering, being a specialist in the tech and life sciences sectors, while Silicon Valley-based Bradley Weber is highly knowledgeable in IPOs and PIPEs. From Boston, Joseph Theis is an expert in securities law and SEC compliance measures, Robert Puopolo stands out for his M&A and joint venture work, and both Marishka DeToy and Gabriela Morales-Rivera are also cited as key for their coverage of SEC compliance and venture capital financing matters.